January 2020 protest in front of the New York Stock Exchange, demanding J&J make bedaquiline more accessible for all people with drug-resistant TB.
Press release |

MSF welcomes Johnson & Johnson's intent not to enforce its patents on key TB drug bedaquiline, paving way for affordable generic versions

Read more
Photo credit: Negin Allamehzadeh

Latest news

What good is a breakthrough medicine if the people who need it can't afford it?